Systematic review of active surveillance for clinically localized prostate cancer to develop recommendations regarding inclusion of intermediate-risk disease, biopsy characteristics at inclusion and monitoring, and surveillance repeat biopsy strategy
Citation
Willemse , P-P M , Davis , N F , Grivas , N , Zattoni , F , Lardas , M , Briers , E , Cumberbatch , M G , De Santis , M , Dell'Oglio , P , Donaldson , J F , Fossati , N , Gandaglia , G , Gillessen , S , Grummet , J P , Henry , A M , Liew , M , MacLennan , S , Mason , M D , Moris , L , Plass , K , O'Hanlon , S , Omar , M I , Oprea-Lager , D E , Pang , K H , Paterson , C , Ploussard , G , Rouvière , O , Schoots , I G , Tilki , D , van den Bergh , R C N , van den Broeck , T , van der Kwast , T H , van der Poel , H G , Wiegel , T , Yuan , C Y , Cornford , P , Mottet , N & Lam , T B L 2022 , ' Systematic review of active surveillance for clinically localized prostate cancer to develop recommendations regarding inclusion of intermediate-risk disease, biopsy characteristics at inclusion and monitoring, and surveillance repeat biopsy strategy ' , European Urology , vol. 81 , no. 4 , pp. 337-346 . https://doi.org/10.1016/j.eururo.2021.12.007
Rights
© 2021. This manuscript version is made available under the CC-BY-NC-ND 4.0 license https://creativecommons.org/licenses/by-nc-nd/4.0/